Preview Mode Links will not work in preview mode

This Week in Cardiology

Jul 16, 2021

COVID-19, Ivermectin, a dissolving pacer, clinician well-being, and finerenone are discussed this week.

1 COVID-19

US 'Losing Time' Against Delta Variant, NIH Chief Says

Ivermectin for COVID: How Do We Know What to Believe?

2 Dissolving Pacemaker

Dissolving Pacemaker Impressive in Early Research

3 Clinician Well-being

Global Heart Organizations Unite to Promote Clinician Well-Being

Clinician Well-Being: Addressing Global Needs for Improvements in the Health Care Field A Joint Opinion From the American College of Cardiology, American Heart Association, European Society of Cardiology, and the World Heart Federation

From Triple to Quadruple Aim: Care of the Patient Requires Care of the Provider

Bullying in Academic Medicine Rife, Underreported

4 Finerenone

FDA Approves Finerenone (Kerendia) for Slowing CKD in Type 2 Diabetes

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact